Organigram Holdings Stock Today
| OGI Stock | CAD 2.61 0.02 0.77% |
Performance2 of 100
| Odds Of DistressLess than 21
|
OrganiGram Holdings is selling at 2.61 as of the 20th of April 2024; that is 0.77 percent up since the beginning of the trading day. The stock's open price was 2.59. OrganiGram Holdings has about a 21 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for OrganiGram Holdings are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 21st of March 2024 and ending today, the 20th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
OrganiGram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. OrganiGram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada. ORGANIGRAM HOLDINGS operates under Drug ManufacturersSpecialty Generic classification in Canada and is traded on Toronto Stock Exchange. The company has 103 M outstanding shares of which 979.64 K shares are now shorted by private and institutional investors with about 1.32 days to cover all short positions. More on OrganiGram Holdings
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
OrganiGram Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. OrganiGram Holdings' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding OrganiGram Holdings or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Gregory Engel | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | ||||
OrganiGram Holdings' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to OrganiGram Holdings' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand OrganiGram Holdings' financial leverage. It provides some insight into what part of OrganiGram Holdings' total assets is financed by creditors.
| |||||
OrganiGram Holdings (OGI) is traded on Toronto Exchange in Canada and employs 984 people. OrganiGram Holdings is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 268.83 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate OrganiGram Holdings's market, we take the total number of its shares issued and multiply it by OrganiGram Holdings's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. OrganiGram Holdings operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 103 M outstanding shares of which 979.64 K shares are now shorted by private and institutional investors with about 1.32 days to cover all short positions.
OrganiGram Holdings has accumulated about 44.78 M in cash with (36.21 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.23.
Check OrganiGram Holdings Probability Of Bankruptcy
Ownership AllocationOrganiGram Holdings has a total of 103 Million outstanding shares. OrganiGram Holdings has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check OrganiGram Ownership Details
OrganiGram Stock Price Odds Analysis
Contingent on a normal probability distribution, the odds of OrganiGram Holdings jumping above the current price in 90 days from now is about 66.25%. The OrganiGram Holdings probability density function shows the probability of OrganiGram Holdings stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon the stock has a beta coefficient of 2.8824. This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, OrganiGram Holdings will likely underperform. Additionally, organiGram Holdings has an alpha of 0.0946, implying that it can generate a 0.0946 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of OrganiGram Holdings to move above the current price in 90 days from now is about 66.25 (This OrganiGram Holdings probability density function shows the probability of OrganiGram Stock to fall within a particular range of prices over 90 days) .
OrganiGram Holdings Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. OrganiGram Holdings market risk premium is the additional return an investor will receive from holding OrganiGram Holdings long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in OrganiGram Holdings. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although OrganiGram Holdings' alpha and beta are two of the key measurements used to evaluate OrganiGram Holdings' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 4.61 | |||
| Semi Deviation | 5.2 | |||
| Standard Deviation | 6.13 | |||
| Variance | 37.6 |
OrganiGram Stock Against Markets
Picking the right benchmark for OrganiGram Holdings stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in OrganiGram Holdings stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for OrganiGram Holdings is critical whether you are bullish or bearish towards OrganiGram Holdings at a given time. Please also check how OrganiGram Holdings' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in OrganiGram Holdings without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Options Analysis Now
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios |
| All Next | Launch Module |
OrganiGram Holdings Corporate Management
Elected by the shareholders, the OrganiGram Holdings' board of directors comprises two types of representatives: OrganiGram Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of OrganiGram. The board's role is to monitor OrganiGram Holdings' management team and ensure that shareholders' interests are well served. OrganiGram Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, OrganiGram Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
| James Cavanagh | Chief of Staff | Profile | |
| Katrina McFadden | Chief Officer | Profile | |
| Peter West | Director | Profile | |
| Megan McCrae | Senior Communications | Profile | |
| Amy Schwalm | Vice President of Investor Relations | Profile | |
| Matthew Rogers | Vice President - Operations | Profile |
How to buy OrganiGram Stock?
Before investing in OrganiGram Holdings, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in OrganiGram Holdings. To buy OrganiGram Holdings stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of OrganiGram Holdings. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase OrganiGram Holdings stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located OrganiGram Holdings stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased OrganiGram Holdings stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as OrganiGram Holdings, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.
Already Invested in OrganiGram Holdings?
The danger of trading OrganiGram Holdings is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of OrganiGram Holdings is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than OrganiGram Holdings. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile OrganiGram Holdings is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether OrganiGram Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of OrganiGram Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organigram Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organigram Holdings Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OrganiGram Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in OrganiGram Stock, please use our How to Invest in OrganiGram Holdings guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for OrganiGram Stock analysis
When running OrganiGram Holdings' price analysis, check to measure OrganiGram Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OrganiGram Holdings is operating at the current time. Most of OrganiGram Holdings' value examination focuses on studying past and present price action to predict the probability of OrganiGram Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OrganiGram Holdings' price. Additionally, you may evaluate how the addition of OrganiGram Holdings to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |